Eton Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 6.67, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Eton Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 55 days, compared to 56 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 243 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2017, from overall ranking in the first quarter 2026 at 2693.

What is Receivable Turnover Ratio?
What is Eton Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ETON Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	72.19 %	-18.24 %	119.31 %	133.98 %	196.59 %
Y / Y Revenue Change	98.63 %	40.77 %	77.14 %	112.14 %	119.38 %
Receivable Turnover Ratio (TTM)	6.67	6.57	5.73	5.69	5.6
ETON's Total Ranking	# 2017	# 2693	# 2470	# 2528	# 2411
Accounts Receivable average collection period days	55	56	64	64	65
Seq. Receivable Change	85.61 %	14.04 %	-10.13 %	-9.49 %	-11.87 %
Seq. Revenue Change	58.37 %	7.4 %	1.12 %	15.49 %	12.24 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 71
Healthcare Sector	# 244
Overall Market	# 2017

Receivable Turnover Ratio Statistics
High	Average	Low
139.37	19.71	4.16
(Mar 31 2021)		(Sep 30 2020)

ETON Company Profile • Back to ETON Efficiency Comparisons • Compare ETON Receivables Turnover Ratio to its Competitors

Financial Statements
Eton Pharmaceuticals Inc 's Accounts Receivable	$ 25 Millions	Visit ETON's Balance sheet
Eton Pharmaceuticals Inc 's Sales TTM	$ 105 Millions	Visit ETON's Income Statement
Sources of ETON's Revenues		Visit ETON's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ETON's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ETON's Growth Rates	ETON's Roa	ETON's Inventory Turnover Ratio	ETON's Dividend Comparisons
ETON's Profitability Ratios	ETON's Roi	ETON's Asset Turnover Ratio	ETON's Dividend Growth
ETON's Valuation Ratios	ETON's Roe	ETON's Financial Strength Ratios	ETON's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Immucell Corporation	10.29	$ 29.777 Millions	$ 2.893 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Lensar Inc	9.75	$ 60.264 Millions	$ 6.184 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
Alumis inc	9.44	$ 7.398 Millions	$ 0.784 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Bioaffinity Technologies Inc	9.11	$ 5.901 Millions	$ 0.648 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biofrontera Inc	8.88	$ 45.956 Millions	$ 5.178 Millions
Guardant Health Inc	8.84	$ 1,183.105 Millions	$ 133.772 Millions
Scientific Industries Inc	8.83	$ 5.728 Millions	$ 0.649 Millions
Cannapharmarx Inc	8.65	$ 1.699 Millions	$ 0.196 Millions
Fate Therapeutics Inc	8.64	$ 6.491 Millions	$ 0.751 Millions
Septerna Inc	8.64	$ 98.882 Millions	$ 11.445 Millions
10x Genomics Inc	8.63	$ 616.566 Millions	$ 71.463 Millions
Tactile Systems Technology Inc	8.58	$ 350.319 Millions	$ 40.851 Millions
Pediatrix Medical Group Inc	8.54	$ 1,950.625 Millions	$ 228.297 Millions
Volitionrx Limited	8.50	$ 2.458 Millions	$ 0.289 Millions
Ensign Group Inc	8.50	$ 5,486.708 Millions	$ 645.470 Millions
Inogen Inc	8.47	$ 354.304 Millions	$ 41.817 Millions

Date modified: 2026-09-03T11:44:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.